A Virtual Pelvic Health Program for Urogenital Impairments After Breast and Gynecologic Cancer: A Proof-of-Concept Study Protocol

Physical therapists and physical therapist assistants who work with people treated for breast or gynecologic cancer, and clinicians interested in how pelvic health services are being delivered virtually.

Licensed physical therapists and physical therapist assistants in outpatient, oncology, women’s health, and telerehabilitation settings. Also relevant to cancer rehabilitation program coordinators and clinicians developing virtual group-based care.

Intended audience

Physical Therapy

Level

Intermediate

Delivery format

Online, asynchronous, self-paced course: interactive reading with audio or video, and a scored post-test.

Based on

This course reports on a single published study protocol. All findings, figures, and conclusions described in the course come from that source.

Bernard S, Perreault K, Pepin D, Gauthier LR, Roy-Richard C, Lamontagne MÈ, Dalzell MA, Mcneely ML. A pelvic health eRehabilitation program to address urogenital impairments after breast and gynecologic cancer: A proof-of-concept study protocol. Digit Health. 2025;11:20552076251382088. doi:10.1177/20552076251382088. PMID: 41018515. PMCID: PMC12461042.

The protocol is registered on ClinicalTrials.gov (registration number NCT06822582). Ethics approval was reported from the Comité éthique de la recherche of the Centre intégré universitaire de santé et des services sociaux de la Capitale-Nationale and from the Health Research Board of Alberta — Cancer Committee.

After completing this course, you will be able to:

1. Describe the three-part structure of the Pelvic Health eRehabilitation Program and the population the protocol states will be enrolled.
2. State the primary aim of this proof-of-concept study and distinguish it from the secondary aim the authors describe as exploratory.
3. Explain the limits the authors acknowledge and what they say the results will be used to inform.

1. Start Here: How This Course Works
2. Podcast Overview: A Virtual Pelvic Health Program After Breast and Gynecologic Cancer (about nine minutes)
3. Urogenital Impairments After Breast and Gynecologic Cancer: The Problem the Program Targets
4. Who Will Be Enrolled and How the Study Is Designed
5. Inside the 12-Week Program: Group Sessions, Individual Follow-Ups, and Online Resources
6. What Will Be Measured, and What a Protocol Cannot Yet Report
7. Limits the Authors Acknowledge and What This Could Mean for Practice
8. Key Takeaways
9. Post-Test and Course Evaluation

Quinn Millington, PT, DPT, ECS is the instructor of record: the licensed clinician who reviewed this course and signed off on it. The name and credentials print on the certificate.

Disclosures. This course was developed by The ConEd Solution, which has a financial interest in its sale. No outside funding or sponsorship was received. The instructor of record has no affiliation with the authors of the source publication or their institutions.

This course awards 0.5 contact hours (30 min). How you earn them:

1. Complete the course. Every lesson, in order.
2. Pass the post-test. Score 80% or higher. Retakes are allowed.
3. Complete the evaluation. A short form rating each learning objective and the course.
4. Download your certificate. It is issued on completion and stays available in My Account.

The episode time is its measured length. Reading, post-test and evaluation times are estimates.

This course is designed to satisfy the quality requirements state boards set for continuing education. Requirements vary by state, and confirming that a course fits your renewal is up to you. Each state’s own acceptance statement is in the credit panel on this page.

1. This course reports on a single published study protocol. All findings, figures, and conclusions described in the course come from that source.
2. Bernard S, Perreault K, Pepin D, Gauthier LR, Roy-Richard C, Lamontagne MÈ, Dalzell MA, Mcneely ML. A pelvic health eRehabilitation program to address urogenital impairments after breast and gynecologic cancer: A proof-of-concept study protocol. Digit Health. 2025;11:20552076251382088. doi:10.1177/20552076251382088. PMID: 41018515. PMCID: PMC12461042.
3. The protocol is registered on ClinicalTrials.gov (registration number NCT06822582). Ethics approval was reported from the Comité éthique de la recherche of the Centre intégré universitaire de santé et des services sociaux de la Capitale-Nationale and from the Health Research Board of Alberta — Cancer Committee.